Extended Use Dates Provided by PfizerExtended Use Dates to Assist with Sterile Water for Injection (small-volumevials in 10 mL, 20 mL, 50 mL and 100 mL presentations) ManufacturedIntermittent Supply Interruptions[October 11, 2018] Due to the intermittent supply interruptions of sterile water for injection, FDA is alerting healthcare professionals and patients of updated dates through which some sterile water for injection, manufactured byHospira, a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patientsafety, these products should have been — and should continue to be — stored as labeled.

Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific batches indicated in the tables below. Patients that have the batch numbers below will be able to use themthrough the corresponding new use dates to help with supply. As data become available, this list can continue toexpand.

FDA is not requiring or recommending that the identified batches in the following tables be relabeled with their newuse dates. However, if replacement product becomes available during the extension period, then the agency expectsthe lots in these tables will be replaced and properly disposed of as soon as possible.

Please see the recent FDA in Brief for more information, and contact CDER Drug Shortage Staff atdrugshortages@fda.hhs.gov (mailto:drugshortages@fda.hhs.gov) with questions regarding these tables.

NDC Number LOT # EXP. DATE NEW EXP. DATE

00409-4887-10 580074P 1-Oct-18 1-Oct-19

00409-4887-10 580084P 1-Oct-18 1-Oct-19

00409-4887-10 580094P 1-Oct-18 1-Oct-19

00409-4887-10 600104P 1-Dec-18 1-Dec-19

00409-4887-10 610104P 1-Jan-19 1-Jan-20

00409-4887-10 610124P 1-Jan-19 1-Jan-20

00409-4887-10 630034P 1-Feb-19 1-Feb-20

00409-4887-10 640064P 1-Feb-19 1-Feb-20

00409-4887-20 640174P 1-Feb-19 1-Feb-20

00409-4887-20 650214P 1-Feb-19 1-Feb-20

mailto:drugshortages@fda.hhs.gov

00409-4887-10 630044P 1-Mar-19 1-Mar-20

00409-4887-10 630064P 1-Mar-19 1-Mar-20

00409-4887-10 630104P 1-Mar-19 1-Mar-20

00409-4887-10 630154P 1-Mar-19 1-Mar-20

00409-4887-10 630144P 1-Mar-19 1-Mar-20

00409-4887-10 640014P 1-Mar-19 1-Mar-20

00409-4887-10 640054P 1-Mar-19 1-Mar-20

00409-4887-10 640074P 1-Mar-19 1-Mar-20

00409-4887-20 58427DK 10/1/2018 10/1/2019

00409-4887-50 58400DK 10/1/2018 10/1/2019

00409-4887-50 58401DK 10/1/2018 10/1/2019

00409-4887-50 58402DK 10/1/2018 10/1/2019

00409-4887-50 58403DK 10/1/2018 10/1/2019

00409-4887-50 58408DK 10/1/2018 10/1/2019

00409-4887-10 58157DK 10/1/2018 10/1/2019

00409-4887-10 58158DK 10/1/2018 10/1/2019

00409-4887-10 58159DK 10/1/2018 10/1/2019

00409-4887-10 58160DK 10/1/2018 10/1/2019

00409-4887-10 58246DK 10/1/2018 10/1/2019

00409-4887-10 58247DK 10/1/2018 10/1/2019

00409-4887-10 58250DK 10/1/2018 10/1/2019

00409-4887-10 58442DK 10/1/2018 10/1/2019

00409-4887-20 59002DK 11/1/2018 11/1/2019

00409-4887-20 59003DK 11/1/2018 11/1/2019

00409-4887-20 59102DK 11/1/2018 11/1/2019

00409-4887-20 59419DK 11/1/2018 11/1/2019

00409-4887-20 59420DK 11/1/2018 11/1/2019

00409-4887-10 59012DK 11/1/2018 11/1/2019

00409-4887-10 59013DK 11/1/2018 11/1/2019

00409-4887-10 59319DK 11/1/2018 11/1/2019

00409-4887-10 59349DK 11/1/2018 11/1/2019

00409-4887-10 59350DK 11/1/2018 11/1/2019

00409-4887-10 59351DK 11/1/2018 11/1/2019

00409-4887-10 59378DK 11/1/2018 11/1/2019

00409-4887-10 59379DK 11/1/2018 11/1/2019

00409-4887-10 59380DK 11/1/2018 11/1/2019

00409-4887-10 59381DK 11/1/2018 11/1/2019

00409-4887-20 60054DK 12/1/2018 12/1/2019

00409-4887-20 60055DK 12/1/2018 12/1/2019

00409-4887-20 60056DK 12/1/2018 12/1/2019

00409-4887-10 60015DK 12/1/2018 12/1/2019

00409-4887-10 60016DK 12/1/2018 12/1/2019

00409-4887-20 61005DK 1/1/2019 1/1/2020

00409-4887-20 61006DK 1/1/2019 1/1/2020

00409-4887-20 61007DK 1/1/2019 1/1/2020

00409-4887-20 61008DK 1/1/2019 1/1/2020

00409-4887-20 61010DK 1/1/2019 1/1/2020

00409-4887-20 61299DK 1/1/2019 1/1/2020

00409-4887-20 61366DK 1/1/2019 1/1/2020

00409-4887-20 61368DK 1/1/2019 1/1/2020

00409-4887-50 61099DK 1/1/2019 1/1/2020

00409-4887-50 61363DK 1/1/2019 1/1/2020

00409-4887-99 61276DK 1/1/2019 1/1/2020

00409-4887-99 61279DK 1/1/2019 1/1/2020

00409-4887-99 61280DK 1/1/2019 1/1/2020

00409-4887-10 61062DK 1/1/2019 1/1/2020

00409-4887-10 61063DK 1/1/2019 1/1/2020

00409-4887-10 61064DK 1/1/2019 1/1/2020

00409-4887-20 62018DK 2/1/2019 2/2/2020

00409-4887-20 62019DK 2/1/2019 2/2/2020

00409-4887-20 62418DK 2/1/2019 2/2/2020

00409-4887-50 62290DK 2/1/2019 2/2/2020

00409-4887-99 62316DK 2/1/2019 2/2/2020

00409-4887-99 62317DK 2/1/2019 2/2/2020

00409-4887-99 62318DK 2/1/2019 2/2/2020

00409-4887-99 62319DK 2/1/2019 2/2/2020

00409-4887-10 62228DK 2/1/2019 2/2/2020

00409-4887-10 62229DK 2/1/2019 2/2/2020

00409-4887-10 62230DK 2/1/2019 2/2/2020

00409-4887-20 63443DK 3/1/2019 3/1/2020

00409-4887-20 63444DK 3/1/2019 3/1/2020

00409-4887-20 63445DK 3/1/2019 3/1/2020

00409-4887-20 63446DK 3/1/2019 3/1/2020

00409-4887-50 63278DK 3/1/2019 3/1/2020

00409-4887-50 63279DK 3/1/2019 3/1/2020

00409-4887-50 63280DK 3/1/2019 3/1/2020

00409-4887-50 63462DK 3/1/2019 3/1/2020

00409-4887-50 63463DK 3/1/2019 3/1/2020

00409-4887-99 63170DK 3/1/2019 3/1/2020

00409-4887-99 63425DK 3/1/2019 3/1/2020

00409-4887-99 63426DK 3/1/2019 3/1/2020

Extended Use Dates to Assist with Sodium Bicarbonate Injection Shortage[September 27, 2018] This is to update the information posted here previously on 6/15/17, 6/23/17, 7/19/17,8/17/17, 11/9/2017, and 6/12/2018. Due to the ongoing critical shortage of injectable drugs used in critical care, FDAis alerting health care professionals and emergency responders of updated dates through which some of theseinjectable drugs, manufactured by Hospira Inc, a Pfizer company, may be used beyond the manufacturer’s labeledexpiration date. To help ensure patient safety, these products should have been — and should continue to be —stored as labeled.

Based on stability data provided by Pfizer and reviewed by FDA, the tables of specific lots with extended use dateshave been updated for the following products:

Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC 0409-6625-02)

Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC 0409-6625-25) LABELLED AS NOVAPLUS

Hospitals that have the following lot numbers in stock will be able to use them through the corresponding new usedates to help with supply. As data become available, this list can continue to expand.

FDA is not requiring or recommending that the identified lots in the following tables be relabeled with their new usedates. However, if replacement product becomes available during the extension period, then it is expected that thelots in these tables will be replaced and properly disposed of as soon as possible.

Please contact CDER Drug Shortage Staff at drugshortages@fda.hhs.gov(https://www.fda.gov/Drugs/DrugSafety/DrugShortages/drugshortages@fda.hhs.gov) with questionsregarding these tables.

Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC0409-6625-02)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

65197EV 1-May-2018 1-Oct-2018

https://www.fda.gov/Drugs/DrugSafety/DrugShortages/drugshortages@fda.hhs.gov

65200EV 1-May-2018 1-Oct-2018

65205EV 1-May-2018 1-Oct-2018

65206EV 1-May-2018 1-Oct-2018

65503EV 1-May-2018 1-Oct-2018

65504EV 1-May-2018 1-Oct-2018

67138EV 1-Jul-2018 1-Dec-2018

67139EV 1-Jul-2018 1-Dec-2018

67140EV 1-Jul-2018 1-Dec-2018

67141EV 1-Jul-2018 1-Dec-2018

67142EV 1-Jul-2018 1-Dec-2018

67248EV 1-Jul-2018 1-Dec-2018

67279EV 1-Jul-2018 1-Dec-2018

67280EV 1-Jul-2018 1-Dec-2018

67281EV 1-Jul-2018 1-Dec-2018

67282EV 1-Jul-2018 1-Dec-2018

67283EV 1-Jul-2018 1-Dec-2018

67284EV 1-Jul-2018 1-Dec-2018

68059EV 1-Aug-2018 1-Jan-2019

68192EV 1-Aug-2018 1-Jan-2019

68193EV 1-Aug-2018 1-Jan-2019

68194EV 1-Aug-2018 1-Jan-2019

68308EV 1-Aug-2018 1-Jan-2019

68309EV 1-Aug-2018 1-Jan-2019

68429EV 1-Aug-2018 1-Jan-2019

68430EV 1-Aug-2018 1-Jan-2019

68431EV 1-Aug-2018 1-Jan-2019

69006EV 1-Sep-2018 1-Feb-2019

69008EV 1-Sep-2018 1-Feb-2019

69180EV 1-Sep-2018 1-Feb-2019

69181EV 1-Sep-2018 1-Feb-2019

69182EV 1-Sep-2018 1-Feb-2019

69353EV 1-Sep-2018 1-Feb-2019

69354EV 1-Sep-2018 1-Feb-2019

69355EV 1-Sep-2018 1-Feb-2019

69356EV 1-Sep-2018 1-Feb-2019

69357EV 1-Sep-2018 1-Feb-2019

69358EV 1-Sep-2018 1-Feb-2019

69361EV 1-Sep-2018 1-Feb-2019

69362EV 1-Sep-2018 1-Feb-2019

69376EV 1-Sep-2018 1-Feb-2019

69379EV 1-Sep-2018 1-Feb-2019

69380EV 1-Sep-2018 1-Feb-2019

70143EV 1-Oct-2018 1-Mar-2019

70316EV 1-Oct-2018 1-Mar-2019

70317EV 1-Oct-2018 1-Mar-2019

70318EV 1-Oct-2018 1-Mar-2019

71055EV 1-Nov-2018 1-Apr-2019

71056EV 1-Nov-2018 1-Apr-2019

71058EV 1-Nov-2018 1-Apr-2019

71079EV 1-Nov-2018 1-Apr-2019

71080EV 1-Nov-2018 1-Apr-2019

71081EV 1-Nov-2018 1-Apr-2019

71154EV 1-Nov-2018 1-Apr-2019

71339EV 1-Nov-2018 1-Apr-2019

Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC0409-6625-25) LABELLED AS NOVAPLUS

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

70064EV 1-Oct-2018 1-Mar-2019

70186EV 1-Oct-2018 1-Mar-2019

70255EV 1-Oct-2018 1-Mar-2019

71110EV 1-Nov-2018 1-Apr-2019

Extended use dates to assist with Aminophylline injection intermittent supply interruptions

[Sept 12, 2018] Due to the intermittent supply interruptions of Aminophylline injection, FDA is alerting health careprofessionals and patients of updated dates through which some Aminophylline injection, manufactured by Hospira,a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patient safety,these products should have been — and should continue to be — stored as labeled.

Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific batches indicated in the tables below. Patients that have the batch numbers below will be able to use themthrough the corresponding new use dates to help with supply. As data become available, this list can continue toexpand.

FDA is not requiring or recommending that the identified batches in the following tables be relabeled with their newuse dates. However, if replacement product becomes available during the extension period, then the agency expectsthe lots in these tables will be replaced and properly disposed of as soon as possible.

Please see the recent FDA in Brief for more information, and contact CDER Drug Shortage Staff atdrugshortages@fda.hhs.gov (mailto:drugshortages@fda.hhs.gov) with questions regarding these tables.

NDC NUMBER LOT # MFG. DATE EXP DATE NEW EXP DATE

00409-5921-01 76328DK 4/12/2017 10/1/2018 2/1/2019

00409-5921-01 76329DK 4/13/2017 10/1/2018 2/1/2019

00409-5921-01 76330DK 4/17/2017 10/1/2018 2/1/2019

mailto:drugshortages@fda.hhs.gov

NDC NUMBER LOT # MFG. DATE EXP DATE NEW EXP DATE

00409-5922-01 76331DK 4/18/2017 10/1/2018 2/1/2019

Extended use dates to assist with EpiPen intermittent supply interruptions

[August 21, 2018] Due to the intermittent supply interruptions of EpiPen, FDA is alerting health care professionalsand patients of updated dates through which some EpiPens and the authorized generic version, manufactured byMeridian Medical Technologies, a Pfizer company, may be used beyond the manufacturer’s labeled expiration date.To help ensure patient safety, these products should have been—and should continue to be—stored as labeled.

Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific batches indicated in the tables below. Patients that have the batch numbers below will be able to use themthrough the corresponding new use dates to help with supply. As data become available, this list can continue toexpand.

FDA is not requiring or recommending that the identified batches in the following tables be relabeled with their newuse dates. However, if replacement product becomes available during the extension period, then the agency expectsthe lots in these tables will be replaced and properly disposed of as soon as possible.

Please see the recent FDA in Brief (/NewsEvents/Newsroom/FDAInBrief/ucm617724.htm) for more information,and contact CDER Drug Shortage Staff at drugshortages@fda.hhs.gov (mailto:drugshortages@fda.hhs.gov)with questions regarding these tables.

Epinephrine Injection, USP 0.3 mg Auto-Injectors NDC 49502-102-02 appears on the box NDC 49502-102-01 appears on the individual device within the box

BatchManufacturer's Original Expiration Date

New Expiration Date (beyond manufacturer's original expiry date)

6FM722 4/2018 8/2018

6FM739 4/2018 8/2018

6FM771 4/2018 8/2018

6FM772 4/2018 8/2018

6FM773 4/2018 8/2018

6FM715 5/2018 9/2018

6FM716 5/2018 9/2018

6FM756 5/2018 9/2018

6FM757 5/2018 9/2018

https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm617724.htmmailto:drugshortages@fda.hhs.gov

BatchManufacturer's Original Expiration Date

New Expiration Date (beyond manufacturer's original expiry date)

6FM768 5/2018 9/2018

6FM780 5/2018 9/2018

6FM781 5/2018 9/2018

6FM782 5/2018 9/2018

6FM783 5/2018 9/2018

6FM785 6/2018 10/2018

6FM787 6/2018 10/2018

7FM115 8/2018 12/2018

7FM117 8/2018 12/2018

7FM120 8/2018 12/2018

7FM134 8/2018 12/2018

7FM174 9/2018 1/2019

7FM175 9/2018 1/2019

7FM274 10/2018 2/2019

7FM275 10/2018 2/2019

7FM276 10/2018 2/2019

Back to Top

EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors NDC 49502-500-02 appears on the box NDC 49502-500-01 appears on the individual device within the box

BatchManufacturer's Original Expiration Date

New Expiration Date (beyond manufacturer's original expiry date)

6GM480 4/2018 8/2018

BatchManufacturer's Original Expiration Date

New Expiration Date (beyond manufacturer's original expiry date)

6GM481 4/2018 8/2018

6GM503 4/2018 8/2018

6GM504 4/2018 8/2018

6GM506 4/2018 8/2018

6GM507 4/2018 8/2018

6GM512 4/2018 8/2018

6GM669 4/2018 8/2018

6GM599 5/2018 9/2018

6GM685 6/2018 10/2018

6GM766 6/2018 10/2018

6GM767 6/2018 10/2018

7GM026 8/2018 12/2018

7GM045 8/2018 12/2018

7GM048 9/2018 1/2019

7GM054 9/2018 1/2019

7GM164 9/2018 1/2019

7GM172 9/2018 1/2019

7GM173 9/2018 1/2019

7GM272 9/2018 1/2019

7GM191 10/2018 2/2019

7GM200 11/2018 3/2019

7GM201 11/2018 3/2019

7GM203 12/2018 4/2019

BatchManufacturer's Original Expiration Date

New Expiration Date (beyond manufacturer's original expiry date)

7GM204 12/2018 4/2019

7GM212 12/2018 4/2019

7GM213 12/2018 4/2019

7GM360 12/2018 4/2019

7GM361 12/2018 4/2019

Back to Top

Extended use dates to assist with emergency syringe shortages

[December 21, 2018] This is to update and consolidate the information posted here previously on 6/15/17, 6/23/17,7/19/17, 8/17/17, 11/9/2017, and 6/12/2017. Due to the ongoing critical shortage of injectable drugs used in criticalcare, FDA is alerting health care professionals and emergency responders of updated dates through which some ofthese injectable drugs, manufactured by Hospira Inc, a Pfizer company, may be used beyond the manufacturer’slabeled expiration date. To help ensure patient safety, these products should have been — and should continue to be— stored as labeled.

Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific lots indicated in the table below for the following products:

Atropine Sulfate Injection, USP 0.1 mg/mL; 5 mL Abboject syringe (NDC 0409-4910-34)

Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL Abboject syringe (NDC 0409-4911-34)

Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL Ansyr Plastic syringe (NDC 0409-1630-10)

Dextrose injection, USP 50% (0.5 g/mL); 25 g/50 mL Abboject syringe (NDC 0409-4902-34)

Dextrose injection, USP 50% (0.5 g/mL); 25 g/50 mL Ansyr Plastic Syringe (NDC 0409-7517-16)

Epinephrine Injection, USP 0.1 mg/mL; 10 mL Abboject syringe (NDC 0409-4921-34) (bundle of 10 syringes) andNDC 0409-4921-20 (1 syringe)

Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Abboject Glass Syringe (18 G x 1 ½"needle) (NDC 0409-6637-34)

Hospitals that have the following lot numbers in stock will be able to use them through the corresponding new usedates to help with supply. As data become available, this list can continue to expand.

FDA is not requiring or recommending that the identified lots in the following tables be relabeled with their new usedates. However, if replacement product becomes available during the extension period, then it is expected that thelots in these tables will be replaced and properly disposed of as soon as possible.

Further information is here (https://www.fda.gov/Drugs/DrugSafety/ucm563378.htm). Please contact CDERDrug Shortage Staff at drugshortages@fda.hhs.gov(https://www.fda.gov/Drugs/DrugSafety/DrugShortages/drugshortages@fda.hhs.gov) with questions

https://www.fda.gov/Drugs/DrugSafety/ucm563378.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/drugshortages@fda.hhs.gov

regarding these tables.

Back to Top

Atropine Sulfate Injection, USP 0.1 mg/mL; 5 mL ABBOJECT syringe (NDC0409-4910-34)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

67331DK00 1-Jul-2018 1-Jan-2019

69292DK00 1-Sep-2018 1-Mar-2019

Back to Top

Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL ABBOJECT syringe (NDC0409-4911-34)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

62470DK00 1-Feb-2018 1-Feb-2019

63292DK00 1-Mar-2018 1-Mar-2019

63293DK00 1-Mar-2018 1-Mar-2019

63318DK00 1-Mar-2018 1-Mar-2019

63319DK00 1-Mar-2018 1-Mar-2019

64271DK00 1-Apr-2018 1-Apr-2019

64301DK00 1-Apr-2018 1-Apr-2019

64302DK00 1-Apr-2018 1-Apr-2019

65255DK00 1-May-2018 1-May-2019

66267DK00 1-Jun-2018 1-Jun-2019

67259DK00 1-Jul-2018 1-Jul-2019

67302DK00 1-Jul-2018 1-Jul-2019

71343DK00 1-Nov-2018 1-Nov-2019

74033DK00 1-Feb-2019 1-Feb-2020

77115DK00 1-May-2019 1-May-2020

77194DK00 1-May-2019 1-May-2020

77237DK00 1-May-2019 1-May-2020

77238DK00 1-May-2019 1-May-2020

77320DK00 1-May-2019 1-May-2020

Back to Top

Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL Ansyr Plastic syringe (NDC0409-1630-10)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

68327EV00 1-Aug-2018 1-Feb-2019

68328EV00 1-Aug-2018 1-Feb-2019

68439EV00 1-Aug-2018 1-Feb-2019

68440EV00 1-Aug-2018 1-Feb-2019

70046EV00 1-Oct-2018 1-Apr-2019

70047EV00 1-Oct-2018 1-Apr-2019

70048EV00 1-Oct-2018 1-Apr-2019

70049EV00 1-Oct-2018 1-Apr-2019

71130EV00 1-Nov-2018 1-May-2019

71197EV00 1-Nov-2018 1-May-2019

71319EV00 1-Nov-2018 1-May-2019

75406EV00 1-Mar-2019 1-Sep-2019

75407EV00 1-Mar-2019 1-Sep-2019

75408EV00 1-Mar-2019 1-Sep-2019

75409EV00 1-Mar-2019 1-Sep-2019

77031EV00 1-May-2019 1-Nov-2019

77033EV00 1-May-2019 1-Nov-2019

77034EV00 1-May-2019 1-Nov-2019

77068EV00 1-May-2019 1-Nov-2019

Back to Top

Dextrose 50% Injection, USP, 50 mL ABBOJECT Syringe (NDC 0409-4902-34)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

63391DK00 1-Mar-2018 1-Mar-2019

63392DK00 1-Mar-2018 1-Mar-2019

63475DK00 1-Mar-2018 1-Mar-2019

64278DK00 1-Apr-2018 1-Apr-2019

64282DK00 1-Apr-2018 1-Apr-2019

65468DK00 1-May-2018 1-May-2019

66007DK00 1-Jun-2018 1-Jun-2019

66387DK00 1-Jun-2018 1-Jun-2019

67040DK00 1-Jul-2018 1-Jul-2019

67041DK00 1-Jul-2018 1-Jul-2019

67042DK00 1-Jul-2018 1-Jul-2019

68082DK00 1-Aug-2018 1-Aug-2019

68458DK00 1-Aug-2018 1-Aug-2019

77099DK00 1-May-2019 1-May-2020

77224DK00 1-May-2019 1-May-2020

77226DK00 1-May-2019 1-May-2020

77232DK00 1-May-2019 1-May-2020

77402DK00 1-May-2019 1-May-2020

Back to Top

Dextrose injection 50% (0.5 g/mL); 25 g/50 mL Ansyr Plastic Syringe (NDC0409-7517-16)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

67171EV00 1-Jul-2018 1-Jan-2019

67329EV00 1-Jul-2018 1-Jan-2019

68009EV00 1-Aug-2018 1-Feb-2019

68010EV00 1-Aug-2018 1-Feb-2019

68011EV00 1-Aug-2018 1-Feb-2019

68187EV00 1-Aug-2018 1-Feb-2019

68188EV00 1-Aug-2018 1-Feb-2019

68189EV00 1-Aug-2018 1-Feb-2019

68190EV00 1-Aug-2018 1-Feb-2019

69098EV00 1-Sep-2018 1-Mar-2019

69099EV00 1-Sep-2018 1-Mar-2019

69100EV00 1-Sep-2018 1-Mar-2019

69101EV00 1-Sep-2018 1-Mar-2019

69102EV00 1-Sep-2018 1-Mar-2019

69188EV00 1-Sep-2018 1-Mar-2019

69189EV00 1-Sep-2018 1-Mar-2019

69190EV00 1-Sep-2018 1-Mar-2019

69191EV00 1-Sep-2018 1-Mar-2019

69192EV00 1-Sep-2018 1-Mar-2019

70189EV00 1-Oct-2018 1-Apr-2019

70190EV00 1-Oct-2018 1-Apr-2019

70191EV00 1-Oct-2018 1-Apr-2019

70192EV00 1-Oct-2018 1-Apr-2019

71190EV00 1-Nov-2018 1-May-2019

71191EV00 1-Nov-2018 1-May-2019

71192EV00 1-Nov-2018 1-May-2019

71193EV00 1-Nov-2018 1-May-2019

71323EV00 1-Nov-2018 1-May-2019

71324EV00 1-Nov-2018 1-May-2019

71325EV00 1-Nov-2018 1-May-2019

71326EV00 1-Nov-2018 1-May-2019

72102EV00 1-Dec-2018 1-Jun-2019

72103EV00 1-Dec-2018 1-Jun-2019

72104EV00 1-Dec-2018 1-Jun-2019

72105EV00 1-Dec-2018 1-Jun-2019

73059EV00 1-Jan-2019 1-Jul-2019

73060EV00 1-Jan-2019 1-Jul-2019

73061EV00 1-Jan-2019 1-Jul-2019

73062EV00 1-Jan-2019 1-Jul-2019

73140EV00 1-Jan-2019 1-Jul-2019

74055EV00 1-Feb-2019 1-Aug-2019

74056EV00 1-Feb-2019 1-Aug-2019

74057EV00 1-Feb-2019 1-Aug-2019

74380EV00 1-Feb-2019 1-Aug-2019

74381EV00 1-Feb-2019 1-Aug-2019

74382EV00 1-Feb-2019 1-Aug-2019

75135EV00 1-Mar-2019 1-Sep-2019

75268EV00 1-Mar-2019 1-Sep-2019

75269EV00 1-Mar-2019 1-Sep-2019

75270EV00 1-Mar-2019 1-Sep-2019

76186EV00 1-Apr-2019 1-Oct-2019

76187EV00 1-Apr-2019 1-Oct-2019

76188EV00 1-Apr-2019 1-Oct-2019

76189EV00 1-Apr-2019 1-Oct-2019

76316EV00 1-Apr-2019 1-Oct-2019

77036EV00 1-May-2019 1-Nov-2019

77037EV00 1-May-2019 1-Nov-2019

77038EV00 1-May-2019 1-Nov-2019

Back to Top

Epinephrine Injection, USP 0.1 mg/mL; 10 mL ABBOJECT syringe (NDC 0409-4921-34) (bundle of 10 syringes) and (NDC 0409-4921-20) (1 syringe)

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

67016DK00 1-Apr-2018 1-Jan-2019

67075DK00 1-Apr-2018 1-Jan-2019

67076DK00 1-Apr-2018 1-Jan-2019

67078DK00 1-Apr-2018 1-Jan-2019

67079DK00 1-Apr-2018 1-Jan-2019

67080DK00 1-Apr-2018 1-Jan-2019

67081DK00 1-Apr-2018 1-Jan-2019

67085DK00 1-Apr-2018 1-Jan-2019

67086DK00 1-Apr-2018 1-Jan-2019

67087DK00 1-Apr-2018 1-Jan-2019

67088DK00 1-Apr-2018 1-Jan-2019

68086DK00 1-May-2018 1-Feb-2019

68087DK00 1-May-2018 1-Feb-2019

68090DK00 1-May-2018 1-Feb-2019

68091DK00 1-May-2018 1-Feb-2019

68092DK00 1-May-2018 1-Feb-2019

68094DK00 1-May-2018 1-Feb-2019

68096DK00 1-May-2018 1-Feb-2019

68097DK00 1-May-2018 1-Feb-2019

68098DK00 1-May-2018 1-Feb-2019

68155DK00 1-May-2018 1-Feb-2019

68156DK00 1-May-2018 1-Feb-2019

68316DK00 1-May-2018 1-Feb-2019

68317DK00 1-May-2018 1-Feb-2019

68398DK00 1-May-2018 1-Feb-2019

69171DK00 1-Jun-2018 1-Mar-2019

69172DK00 1-Jun-2018 1-Mar-2019

69273DK00 1-Jun-2018 1-Mar-2019

69274DK00 1-Jun-2018 1-Mar-2019

69278DK00 1-Jun-2018 1-Mar-2019

70265DK00 1-Jul-2018 1-Apr-2019

76158DK00 1-Jan-2019 1-Oct-2019

76159DK00 1-Jan-2019 1-Oct-2019

77113DK00 1-Feb-2019 1-Nov-2019

77114DK00 1-Feb-2019 1-Nov-2019

77117DK00 1-Feb-2019 1-Nov-2019

77118DK00 1-Feb-2019 1-Nov-2019

77195DK00 1-Feb-2019 1-Nov-2019

77196DK00 1-Feb-2019 1-Nov-2019

77197DK00 1-Feb-2019 1-Nov-2019

77240DK00 1-Feb-2019 1-Nov-2019

77241DK00 1-Feb-2019 1-Nov-2019

77242DK00 1-Feb-2019 1-Nov-2019

77408DK00 1-Feb-2019 1-Nov-2019

Back to Top

Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL AbbojectGlass Syringe (18 G x 1 ½" needle (NDC 0409-6637-34))

Product/ Lot Number

Manufacturer’s Original Expiry Date

New Use Date (beyond manufacturer’s originalexpiry date)

67045DK00 1-Jul-2018 1-Jan-2019

67046DK00 1-Jul-2018 1-Jan-2019

67047DK00 1-Jul-2018 1-Jan-2019

68040DK00 1-Aug-2018 1-Feb-2019

68041DK00 1-Aug-2018 1-Feb-2019

68079DK00 1-Aug-2018 1-Feb-2019

68080DK00 1-Aug-2018 1-Feb-2019

68336DK00 1-Aug-2018 1-Feb-2019

68405DK00 1-Aug-2018 1-Feb-2019

68406DK00 1-Aug-2018 1-Feb-2019

68407DK00 1-Aug-2018 1-Feb-2019

69128DK00 1-Sep-2018 1-Mar-2019

69129DK00 1-Sep-2018 1-Mar-2019

69131DK00 1-Sep-2018 1-Mar-2019

69132DK00 1-Sep-2018 1-Mar-2019

69133DK00 1-Sep-2018 1-Mar-2019

69134DK00 1-Sep-2018 1-Mar-2019

69142DK00 1-Sep-2018 1-Mar-2019

69144DK00 1-Sep-2018 1-Mar-2019

69270DK00 1-Sep-2018 1-Mar-2019

69271DK00 1-Sep-2018 1-Mar-2019

69346DK00 1-Sep-2018 1-Mar-2019

69395DK00 1-Sep-2018 1-Mar-2019

69396DK00 1-Sep-2018 1-Mar-2019

69397DK00 1-Sep-2018 1-Mar-2019

70351DK00 1-Oct-2018 1-Apr-2019

73127DK00 1-Jan-2019 1-Jul-2019

73128DK00 1-Jan-2019 1-Jul-2019

73129DK00 1-Jan-2019 1-Jul-2019

73337DK00 1-Jan-2019 1-Jul-2019

74344DK00 1-Feb-2019 1-Aug-2019

76026DK00 1-Apr-2019 1-Oct-2019

76027DK00 1-Apr-2019 1-Oct-2019

76028DK00 1-Apr-2019 1-Oct-2019

76029DK00 1-Apr-2019 1-Oct-2019

76074DK00 1-Apr-2019 1-Oct-2019

76297DK00 1-Apr-2019 1-Oct-2019

76301DK00 1-Apr-2019 1-Oct-2019

76302DK00 1-Apr-2019 1-Oct-2019

76368DK00 1-Apr-2019 1-Oct-2019

77101DK00 1-May-2019 1-Nov-2019

77102DK00 1-May-2019 1-Nov-2019

77103DK00 1-May-2019 1-Nov-2019

77106DK00 1-May-2019 1-Nov-2019

77107DK00 1-May-2019 1-Nov-2019

77108DK00 1-May-2019 1-Nov-2019

77227DK00 1-May-2019 1-Nov-2019

77228DK00 1-May-2019 1-Nov-2019

77230DK00 1-May-2019 1-Nov-2019

77233DK00 1-May-2019 1-Nov-2019

77234DK00 1-May-2019 1-Nov-2019

77235DK00 1-May-2019 1-Nov-2019

78194DK00 1-Jun-2019 1-Dec-2019

78195DK00 1-Jun-2019 1-Dec-2019

78238DK00 1-Jun-2019 1-Dec-2019

78241DK00 1-Jun-2019 1-Dec-2019

78242DK00 1-Jun-2019 1-Dec-2019

78243DK00 1-Jun-2019 1-Dec-2019

78326DK00 1-Jun-2019 1-Dec-2019

Back to Top

Drug Shortages: Additional News and Information (/Drugs/DrugSafety/DrugShortages/ucm349561.htm)

Frequently Asked Questions about Drug Shortages (/Drugs/DrugSafety/DrugShortages/ucm050796.htm)

Drug Shortages Infographic (/Drugs/DrugSafety/DrugShortages/ucm441579.htm)

More in Drug Shortages(/Drugs/DrugSafety/DrugShortages/default.htm)

https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm349561.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050796.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm441579.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm